Drug Shortage Report for BIO-OMEPRAZOLE
| Report ID | 241101 |
| Drug Identification Number | 02449927 |
| Brand name | BIO-OMEPRAZOLE |
| Common or Proper name | OMEPRAZOLE |
| Company Name | BIOMED PHARMA |
| Market Status | MARKETED |
| Active Ingredient(s) | OMEPRAZOLE |
| Strength(s) | 20MG |
| Dosage form(s) | TABLET (DELAYED-RELEASE) |
| Route of administration | ORAL ORAL |
| Packaging size | 100 |
| ATC code | A02BC |
| ATC description | DRUGS FOR PEPTIC ULCER AND GASTROESOPHAGEAL REFLUX DISEASE (GERD) |
| Reason for shortage | Requirements related to complying with good manufacturing practices. |
| Anticipated start date | 2024-10-17 |
| Actual start date | 2024-10-17 |
| Estimated end date | Unknown |
| Actual end date | |
| Shortage status | Actual shortage |
| Updated date | 2024-12-23 |
| Company comments | Recherche de fournisseur alternatif |
| Health Canada comments | |
| Tier 3 Status | No |
| Contact Address | 9450 BOUL. LANGELIER MONTREAL, QUEBEC CANADA H1P 3H8 |
| Company contact information |
Version History
Click on "Compare" below to view the full report history and compare to other versions.
| Version Number | Date Updated | Language | |
|---|---|---|---|
| v6 | 2024-12-23 | English | Compare |
| v5 | 2024-12-23 | English | Compare |
| v4 | 2024-12-18 | French | Compare |
| v3 | 2024-12-18 | English | Compare |
| v2 | 2024-10-24 | French | Compare |
| v1 | 2024-10-24 | English | Compare |
Showing 1 to 6 of 6